SUMO2 pseudogene 20 (SUMO2P20)

SUMO2 pseudogene 20 is a member of a group of genomic sequences resembling the SUMO2 gene, but it is considered a *pseudogene*, meaning it does not code for functional SUMO2 protein and typically contains sequence disruptions or mutations[6][3][5]. While the canonical SUMO2 gene encodes an active member of the small ubiquitin-like modifier family involved in post-translational modification, nuclear transport, DNA repair, and regulation of gene expression[1][2][3][5], SUMO2 pseudogene 20 cannot perform these roles. In general, pseudogenes may play minor or regulatory roles in genome evolution but are not considered molecular targets for drug development or functional cell biology resources, nor are they directly studied in disease or therapeutic research.

None. Drugs do not target pseudogenes directly, and SUMO2P20 is not an active molecular target[6][3][5].